NORMA BRACAMONTE: Open Payments
NPI 1851757603 · ORO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 29 payments from 11 companies in 2025. Trend: 2023 $41 · 2024 $238 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $320 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| GENZYME CORPORATION | 3 | $88 |
| CSL Behring | 3 | $74 |
| Genentech USA, Inc. | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| BioCryst US Sales Co., LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, Hizentra, Xolair, NEFFY, ORLADEYO, EBGLYSS.
Industry payments across AZ — which companies pay providers there.
